Date published: 2025-9-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

1600014C10Rik Inhibitors

Chemical inhibitors of the protein encoded by 1600014C10Rik can play a significant role in modulating its activity within cellular signaling pathways. For instance, Wortmannin and LY294002 are both inhibitors of phosphoinositide 3-kinases (PI3K), and their interaction with the PI3K pathway can lead to the functional inhibition of the protein. When PI3K is inhibited, the activation or signaling pathways that the protein encoded by 1600014C10Rik might be involved in are likely to be impeded. This effect is due to the pivotal role PI3K plays in various cellular processes such as cell growth, proliferation, and survival, which are often regulated by the downstream signaling of PI3K. Similarly, Staurosporine, a potent protein kinase inhibitor, has a broad spectrum of targets and can suppress the activity of the protein encoded by 1600014C10Rik if it is a kinase or is regulated by phosphorylation events.

Furthermore, Rapamycin, by inhibiting mTOR, can result in the downregulation of the protein encoded by 1600014C10Rik if the protein functions within mTOR signaling pathways. mTOR is a central cell growth regulator, and its inhibition can lead to reduced activity of proteins associated with its pathway. In the MAPK/ERK pathway, PD0325901 and U0126, both MEK inhibitors, would preclude the necessary phosphorylation events for proteins that are regulated by this pathway, which could include the protein encoded by 1600014C10Rik. Additionally, SP600125 and SB203580, specific inhibitors of JNK and p38 MAPK respectively, could also lead to the inhibition of the protein if it is involved in stress response pathways governed by JNK or p38 MAPK. Dasatinib and PP2, as tyrosine kinase inhibitors, specifically target the phosphorylation process that is essential for the activation and function of many proteins. If the protein encoded by 1600014C10Rik is a tyrosine kinase or is activated by one, these inhibitors can suppress its activity. Lastly, Gefitinib and Sorafenib, which target EGFR and RAF kinases respectively, can modulate the activity of the protein encoded by 1600014C10Rik by obstructing the signaling cascades these kinases are part of, assuming the protein interacts with or is a component of these pathways.

SEE ALSO...

Items 151 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING